title: Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animals.
authors.affiliation: Department of Surgery, University of Toronto, Ontario, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Abecassis
authors.forename: J
authors.initials: J
authors.lastname: Falk
authors.forename: V
authors.initials: V
authors.lastname: Dindzans
authors.forename: W
authors.initials: W
authors.lastname: Lopatin
authors.forename: L
authors.initials: L
authors.lastname: Makowka
authors.forename: G
authors.initials: G
authors.lastname: Levy
authors.forename: R
authors.initials: R
authors.lastname: Falk
mesh_terms: D000818:Animals; D001779:Blood Coagulation Factors / Q000032:analysis*; D002478:Cells, Cultured; D015232:Dinoprostone / Q000627:therapeutic use*; D004198:Disease Susceptibility; D006524:Hepatitis, Viral, Animal / Q000473:pathology / Q000517:prevention & control*; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000473:pathology; D008264:Macrophages / Q000187:drug effects / Q000382:microbiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D006517:Murine hepatitis virus; D009336:Necrosis; D012016:Reference Values
chemical_list: D001779:Blood Coagulation Factors; C045072:macrophage procoagulant activity; D015232:Dinoprostone